Q3 2024 PEMGARDAâ„¢ (pemivibart) net product revenue of $9.3 million; Invivyd ended Q3 2024 with $106.9 million in cash and cash equivalentsTargets ...
"Very high" levels of the virus were detected by the CDC in New Mexico, with "high" levels in Oregon, Arkansas, and Maine.
A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...
Leerink Partners analyst Mani Foroohar maintained a Hold rating on CureVac (CVAC – Research Report) on November 12. The company’s ...
Zymo’s Quick DNA/RNA Viral MagBead Kit was automated using Analytik Jena’s Cybio FeliX pipetting robot. The CyBio FeliX ...
The manuscript was released online ahead of publication in The Journal of Molecular Diagnostics. AMP convened a SARS-CoV-2 Whole Genome Sequencing Working Group with organizational representation from ...
The latest COVID-19 treatment, using an inhibitor of the Fas ligand (FasL), also known as CD95 ligand (CD95L), speeds up ...
They had built protocols around going to wastewater plants, getting material, and isolating viruses. “We had the idea that ...
The risk for VTE was reduced among Military Health Systems beneficiaries who were vaccinated vs unvaccinated against COVID-19.
A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...
In addition, annual estimates of RSV-associated ICU admissions ranged from 24,400 to 34,900 for the 2016-2017 and 2017-2018 ...
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...